Second-Generation Antipsychotics Do Not Raise Risk of Major Malformations
The Carlat Psychiatry Report, Volume 14, Number 5, May 2016
https://www.thecarlatreport.com/newsletter-issue/tcprv14n5/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | Psychopharmacology Tips | Research Update
Bret A. Moore, PsyD, ABPP
Board-Certified Clinical Psychologist, San Antonio, TX
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Second-generation antipsychotics (SGA) are used for a variety of psychiatric conditions, but even though they’ve been around for 20 years, we know little about what impact they have on the developing fetus. These medications are widely considered to be relatively safe during pregnancy, but this assumption is based on scant evidence. In this paper, researchers tapped into the Massachusetts General Hospital (MGH) National Pregnancy Registry of Atypical Antipsychotics and reported some reassuring results.
You can't view details of this content, please login or buy subscription here